BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19714874)

  • 1. Combination of 1H nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry with pattern recognition techniques for evaluation of metabolic profile associated with albuminuria.
    Law WS; Huang PY; Ong ES; Sethi SK; Saw S; Ong CN; Li SF
    J Proteome Res; 2009 Apr; 8(4):1828-37. PubMed ID: 19714874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary metabonomics study in a rat model in response to protein-energy malnutrition by using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
    Wu Z; Li M; Zhao C; Zhou J; Chang Y; Li X; Gao P; Lu X; Li Y; Xu G
    Mol Biosyst; 2010 Nov; 6(11):2157-63. PubMed ID: 20717558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
    Anthony ML; Sweatman BC; Beddell CR; Lindon JC; Nicholson JK
    Mol Pharmacol; 1994 Jul; 46(1):199-211. PubMed ID: 8058053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery.
    Sieber M; Wagner S; Rached E; Amberg A; Mally A; Dekant W
    Chem Res Toxicol; 2009 Jul; 22(7):1221-31. PubMed ID: 19610676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
    Teul J; Rupérez FJ; Garcia A; Vaysse J; Balayssac S; Gilard V; Malet-Martino M; Martin-Ventura JL; Blanco-Colio LM; Tuñón J; Egido J; Barbas C
    J Proteome Res; 2009 Dec; 8(12):5580-9. PubMed ID: 19813770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.
    Novak P; Tepes P; Fistrić I; Bratos I; Gabelica V
    J Pharm Biomed Anal; 2006 Mar; 40(5):1268-72. PubMed ID: 16253464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
    Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
    Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based metabolic profiling of rat urine associated with general toxicity induced by the multiglycoside of Tripterygium wilfordii Hook. f.
    Chen M; Ni Y; Duan H; Qiu Y; Guo C; Jiao Y; Shi H; Su M; Jia W
    Chem Res Toxicol; 2008 Feb; 21(2):288-94. PubMed ID: 18205320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large scale pesticide multiresidue methods in food combining liquid chromatography--time-of-flight mass spectrometry and tandem mass spectrometry.
    García-Reyes JF; Hernando MD; Ferrer C; Molina-Díaz A; Fernández-Alba AR
    Anal Chem; 2007 Oct; 79(19):7308-23. PubMed ID: 17718536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance and liquid chromatography-mass spectrometry combined with an incompleted separation strategy for identifying the natural products in crude extract.
    Dai D; He J; Sun R; Zhang R; Aisa HA; Abliz Z
    Anal Chim Acta; 2009 Jan; 632(2):221-8. PubMed ID: 19110097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-mass spectrometric analysis of urinary metabolites and their pattern recognition for the prediction of drug-induced hepatotoxicity.
    La S; Yoo HH; Kim DH
    Chem Res Toxicol; 2005 Dec; 18(12):1887-96. PubMed ID: 16359179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data.
    Idborg H; Zamani L; Edlund PO; Schuppe-Koistinen I; Jacobsson SP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):14-20. PubMed ID: 16198158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.
    Wang C; Kong H; Guan Y; Yang J; Gu J; Yang S; Xu G
    Anal Chem; 2005 Jul; 77(13):4108-16. PubMed ID: 15987116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
    Bu HZ; Poglod M; Micetich RG; Khan JK
    J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural classification of acyl-substituted Quillaja saponins by electrospray ionisation ion trap multiple-stage mass spectrometry in combination with multivariate analysis.
    Bankefors J; Nord LI; Kenne L
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3851-60. PubMed ID: 18985635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.